The strengths of the present review are its comprehensive update of randomized evidence through the end of 2025, its focus on medications relevant to contemporary European practice, and its integration of anthropometric, metabolic, complication-specific, safety and GRADE-based assessments within a single framework
Losing Pounds, Gaining Health What are the benefits of Semaglutide
As a scientist following the GLP-1 data with great interest, I was excited to see this study
Song, M., Zhang, F., Fu, Y., Yi, X., Feng, S., Liu, Z., Deng, D., Yang, Q., Yu, M., Zhu, C., Zhu, X., Wang, L., Gao, P., Shu, G., Ma, X., Jiang, Q., & Wang, S
doi: 10.1016/j.pnpbp.2022.110694 69 HanQ
Some people get prescribed medication